Financial Turnaround for Glasgow’s Collagen Solutions

Collagen Solutions, the Glasgow-based life sciences firm, is forecasting a double-digit hike in revenues and narrower-than-expected losses, marking a “substantial” turnaround in its financial fortunes. In a trading update, the group said revenue for the full year was expected to be ahead of market expectations at £4.15 million, reflecting year-on-year growth of 18 per cent. Revenue from agreements to develop collagen products on behalf of...

The £150k prize fund: Scottish EDGE Round 14 opens today

The 14th round of the Scottish EDGE competition opens today for applications.  Scottish EDGE identifies and supports the nation’s most innovative, high growth potential entrepreneurs and Round 14 includes the special Higgs award for science, technology and engineering focused businesses – a prize fund of £150,000.  Applications will be taken until March 4th – that’s just 5 weeks away. Previous big winners from our sector...

Take on the biggest healthcare challenges: apply for funding

UK businesses can apply for a share of up to £10 million to develop technologies, products and processes that could offer better outcomes for patients. The Biomedical Catalyst supports UK businesses to test and develop innovative technologies for healthcare. New healthcare technologies, products and processes could transform the life sciences sector and improve the lives of patients. Through the Biomedical Catalyst – a partnership between Innovate UK...

ROSLINCT and REPROCELL awarded £1.2 million project from Innovate UK for clinical-grade stem cell production

Funding will be used to improve the efficiency of induced pluripotent stem cell production.  Edinburgh, UK and Glasgow, UK: ROSLINCT, a leading cell and gene therapy contract manufacturing organisation, today announced it is to receive investment to collaborate with REPROCELL Europe Ltd (REPROCELL), a UK-based stem cell company, on a £1.2million project which will develop a faster, more cost-effective method of producing clinical-grade induced pluripotent stem...

Rugby star’s pledge aids bid for MND therapies

Scientists are to use lab tests to investigate whether drugs that already treat a range of conditions could help people with motor neurone disease. The initiative could cut years spent waiting for treatments to become available because the drugs being tested are known to be safe. Researchers at the University of Edinburgh have received £250,000 from the My Name’5 Doddie Foundation, launched by former rugby...

Top